Luz Chamorro Luz Chamorro Luz Chamorro
About me
Luz Rocio Chamorro Correa is a Paraguayan scientist and PhD candidate in Genomic Sciences and Biotechnology in Brazil. Her research focuses on fungal genomics, antifungal resistance, and the evolution of pathogens causing neglected endemic mycoses, particularly paracoccidioidomycosis and chromoblastomycosis. She is passionate about using genomics and bioinformatics to address neglected diseases and about strengthening scientific collaboration and opportunities for women researchers in Latin America and the Global South.
Luz Rocio Chamorro Correa is a Paraguayan scientist and PhD candidate in Genomic Sciences and Biotechnology at the Catholic University of Brasília, Brazil. Her research focuses on fungal pathogens, genomic diversity, antifungal resistance, and adaptive evolution, with a particular interest in neglected endemic mycoses.
She holds a Bachelor's degree in Biochemistry from the National University of Asunción, Paraguay, and a Master's degree in Molecular Pathology from the University of Brasília. During her academic career, she has worked on paracoccidioidomycosis and chromoblastomycosis, combining clinical epidemiology, fungal genomics, and antimicrobial susceptibility testing to better understand fungal diseases that disproportionately affect underserved populations.
Her current PhD research investigates genomic diversity, antifungal resistance, and adaptive evolution in the agents of chromoblastomycosis, as part of a Brazilian national research network on antifungal resistance. She is particularly interested in using genomic and bioinformatic approaches to generate knowledge that can contribute to improved surveillance, diagnosis, and management of neglected fungal diseases.
As a scientist from Paraguay working in Brazil, Luz is passionate about strengthening scientific collaboration across Latin America and promoting greater visibility for neglected diseases and researchers from the Global South. She is interested in building an international career at the intersection of genomics, infectious diseases, and global health, while contributing to more inclusive opportunities for women in science.